Impact of antimicrobial residues on gut communities: Are the new regulations effective?

Journal of Applied Microbiology

Volumn 102, Issue 5, 2007, Pages 1220-1226

  Silley, P ^a,b  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Antimicrobial residues; Gut flora; Regulation; Veterinary medicine

Indexed keywords

HEALTH RISKS; MICROORGANISMS; RISK PERCEPTION;

ACCEPTABLE DAILY INTAKES; ANTIMICROBIAL RESIDUE; BODY WEIGHT; COMMUNITY IS; FOOD-PRODUCING ANIMALS; GUT COMMUNITY; GUT FLORA; HUMAN INTESTINAL FLORAS; REGULATION; RIGOROUS EVALUATION;

VETERINARY MEDICINE;

ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; DRUG; FOOD SAFETY; HEALTH POLICY; HEALTH RISK; MEDICINE; RISK FACTOR; STANDARD (REGULATION);

BACTERIAL COLONIZATION; COLON FLORA; CONFERENCE PAPER; DRUG MONITORING; FOOD CONTROL; FOOD INDUSTRY; FOOD MICROBIOTECHNOLOGY; FOOD SAFETY; INTESTINE FLORA; INTESTINE MUCOSA; MEAT INDUSTRY; PRACTICE GUIDELINE;

ANIMALIA;

EID: 34247330902     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2007.03288.x     Document Type: Conference Paper

References (22)

1. Brumfitt, W., Franklin, I., Grady, D., Hamilton-Miller, J.M.T. Iliffe, A. (1984) Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother 26, 757 761.
2. Cerniglia, C.E. Kotarski, S. (2005) Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora. J Vet Pharmacol Ther 28, 3 20.
3. CVMP/VICH/467/03-FINAL (2004) Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to establish a microbiological ADI. (VICH Guideline 36). http://www.emea.europa.eu/pdfs/vet/ vich/046703en.pdf.
4. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E. et al. (2005) Diversity of the human intestinal microbial flora. Science 308, 1635 1638.
5. Edlund, C. Nord, C.E. (1999) Effect of quinolones on intestinal ecology. Drugs 58 (Suppl 2 65 70.
6. Edlund, C. Nord, C.E. (2001) The evaluation and prediction of the ecologic impact of antibiotics in human phase I and II trials. Clin Microbiol Infect 7 (Suppl 5 37 41.
7. Engelkirk, P.G., Dubin-Engelkirk, J. Dowell, V.R. (1992) Principles and Practice of Clinical Anaerobic Bacteriology. Belmont, CA, USA: Star Publishing Company.
8. Enzensberger, R., Shah, P.M. Knothe, H. (1985) Impact of oral ciprofloxacin on the faecal flora of healthy volunteers. Infection 12, 273 275.
9. Flint, H.J. (2006) The significance of prokaryote diversity in the human gastrointestinal tract. SGM Symposium 66, 65 90.
10. Hold, G.L., Pryde, S.E., Russell, V.J., Furrie, E. Flint, H.J. (2002) Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol 39, 33 39.
11. Hooper, L.V. (2004) Bacterial contributions to mammalian gut development. Trends Microbiol 12, 129 134.
12. JECFA (1997) Enrofloxacin. In Toxicological Evaluation of Certain Veterinary Drug Residues in Food. WHO Food Additive Series 39, prepared by the 48th Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), pp. 47 61. Geneva, Switzerland: World Health Organization.
13. Livingston, S.J., Kominos, S.D. Yee, R.B. (1978) New medium for selection and presumptive identification of the Bacteroides fragilis group. J Clin Microbiol 7, 448 453.
14. Nord, C.E., Rasmanis, G. Wahlund, E. (2006a) Effect of dalbavancin on the normal intestinal microflora. J Antimicrob Chemother 58, 627 631.
15. Nord, C.E., Sillerstrom, E. Wahlund, E. (2006b) Effect of tigecycline on normal oropharyngeal and intestinal microflora. Antimicrob Agents Chemother 50, 3375 3380.
16. Pecquet, S., Andremont, A. Tancrède, C. (1986) Selective antimicrobial modulation of the intestinal tract by Norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora. Antimicrob Agents Chemother 29, 1047 1052.
17. Pecquet, S., Andremont, A. Tancrède, C. (1987) Effect of oral ofloxacin on fecal bacteria in human volunteers. Antimicrob Agents Chemother 31, 124 125.
18. Pecquet, S., Ravoire, S. Andremont, A. (1990) Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers. J Antimicrob Chemother 26, 125 129.
19. Phillips, I., Casewell, M., Cox, T., de Groot, B., Friis, C., Jones, R., Nightingale, C., Preston, R. et al. (2004) Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother 53, 28 52.
20. Suau, A.R., Bonnet, R., Sutren, M., Gordon, J.J., Gibson, G.R., Collins, M.D. Dore, J. (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65, 4799 4807.
21. Sullivan, A., Edlund, C. Nord, C.E. (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1, 101 114.
22. Vanhoutte, T., De Preter, V., De Brandt, E., Verbeke, K., Swings, J. Huys, G. (2006) Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl Environ Microbiol 72, 5990 5997.